7 results
8-K
EX-99.1
TCRX
Tscan Therapeutics Inc
9 May 23
Amgen and Tscan Therapeutics Announce Collaboration to Identify Novel Targets In Crohn’s Disease
9:15am
. In 2022, Amgen was named one of the “World’s Best Employers” by Forbes and one of “America’s 100 Most Sustainable Companies” by Barron’s.
For more
424B4
TCRX
Tscan Therapeutics Inc
19 Jul 21
Prospectus supplement with pricing info
7:01am
of this offering or, if it does develop, it may not be sustainable. The market price of our common stock may fluctuate significantly in response to numerous factors
S-1/A
TCRX
Tscan Therapeutics Inc
30 Apr 21
IPO registration (amended)
5:00pm
. An active or liquid market in our common stock may not develop upon the completion of this offering or, if it does develop, it may not be sustainable
S-1
ojbdofh
23 Apr 21
IPO registration
5:15pm
DRS
s2ifhq1q3tz8xi
19 Mar 21
Draft registration statement
12:00am
- Prev
- 1
- Next